Andere Kunden interessierten sich auch für
![Pseudo Random Arterial Modulation (PRAM)]( "Pseudo Random Arterial Modulation (PRAM)")
Pseudo Random Arterial Modulation (PRAM)32,99 €![Androgen Receptor Modulation in Prostate Cancer]( "Androgen Receptor Modulation in Prostate Cancer")
Androgen Receptor Modulation in Prostate Cancer38,99 €![Modulation of HIV Co-Receptor Expression on Cells by Anti-Virals]( "Modulation of HIV Co-Receptor Expression on Cells by Anti-Virals")
Modulation of HIV Co-Receptor Expression on Cells by Anti-Virals32,99 €![Percutaneous coronary intervention in ischemic cardiomyopathy]( "Percutaneous coronary intervention in ischemic cardiomyopathy")
Percutaneous coronary intervention in ischemic cardiomyopathy44,99 €![Experimental biology and Molecular Pathology]( "Experimental biology and Molecular Pathology")
Experimental biology and Molecular Pathology32,99 €![Insulin-like growth factors and diabetic embryopathy]( "Insulin-like growth factors and diabetic embryopathy")
Insulin-like growth factors and diabetic embryopathy51,99 €![Biochemical Modulation of Anticancer Agents: Experimental and Clinical Approaches]( "Biochemical Modulation of Anticancer Agents: Experimental and Clinical Approaches")
Biochemical Modulation of Anticancer Agents: Experimental and Clinical Approaches185,99 €
Different types of cardiomyopathies are associated with variable hypertrophic response. A number of growth factors are thought to play a role in pathologic cardiac remodeling. We compared the modulation of the TGF- superfamily and IGF-1 signaling pathways and their target genes, the cell cycle regulatory proteins in tachycardia-induced dilated cardiomyopathy, a model with no detectable hypertrophy and in ischemic cardiomyopathy, a model with a marked hypertrophic reaction. Tachycardiomyopathy was characterized by chambers dilation with no identifiable hypertrophy. Ischemic cardiomyopathy was characterized by eccentric hypertrophy.